(Q50589541)
Statements
Dosimetry-guided high-activity (131)I therapy in patients with advanced differentiated thyroid carcinoma: initial experience. (English)
1 reference
Frederik A Verburg
1 reference
Heribert Hänscheid
1 reference
Johannes Biko
1 reference
Maria C Hategan
1 reference
Michael C Kreissl
1 reference
Christoph Reiners
1 reference
Markus Luster
1 reference
24 December 2009
1 reference
37
1 reference
5
1 reference
896-903
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference